All Pharma News
XOMA Corporation Announces Closing of Tender Offer

XOMA Corporation Announces Closing of Tender Offer
GLOBENEWSWIRE
03 Apr 2024
Share Share
XOMA Announces Expiration Date for Tender Offer for Kinnate Biopharma Inc.

XOMA Announces Expiration Date for Tender Offer for Kinnate Biopharma Inc.
GLOBENEWSWIRE
19 Mar 2024
Share Share
Kinnate Sells Pan-RAF Inhibitor Exarafenib To Pierre Fabre

Kinnate Sells Pan-RAF Inhibitor Exarafenib To Pierre Fabre
PRESS RELEASE
05 Mar 2024
Share Share
Kinnate Sells Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre

Kinnate Sells Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre
PR NEWSWIRE
01 Mar 2024
Share Share
Kinnate Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre

Kinnate Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre
GLOBENEWSWIRE
01 Mar 2024
Share Share
XOMA Enters into Agreement to Acquire Kinnate Biopharma

XOMA Enters into Agreement to Acquire Kinnate Biopharma
GLOBENEWSWIRE
16 Feb 2024
Share Share
Kinnate Biopharma Inc. Reports Third Quarter 2023 Financial Results

Kinnate Biopharma Inc. Reports Third Quarter 2023 Financial Results
GLOBENEWSWIRE
09 Nov 2023
Share Share
Kinnate lays off 70% of staff, pulls back from programs

Kinnate lays off 70% of staff, pulls back from programs
Nick Paul Taylor FIERCE BIOTECH
19 Sep 2023
Share Share
Kinnate Biopharma Inc. Announces Pipeline Updates

Kinnate Biopharma Inc. Announces Pipeline Updates
GLOBENEWSWIRE
18 Sep 2023
Share Share
Kinnate Biopharma Inc. Reports Second Quarter 2023 Financial Results

Kinnate Biopharma Inc. Reports Second Quarter 2023 Financial Results
GLOBENEWSWIRE
08 Aug 2023
Share Share